サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：使い捨て皮下注射器の世界市場 - 成長、将来の見通し、競合分析（2022年～2030年）
市場調査レポート
商品コード
1134296

使い捨て皮下注射器の世界市場 - 成長、将来の見通し、競合分析（2022年～2030年）

Disposable Hypodermic Syringes Market - Growth, Future Prospects and Competitive Analysis, 2022 - 2030
出版日: | 発行: Acute Market Reports | ページ情報: 英文 112 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
使い捨て皮下注射器の世界市場 - 成長、将来の見通し、競合分析（2022年～2030年）
出版日: 2022年08月08日
発行: Acute Market Reports
ページ情報: 英文 112 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の使い捨て皮下注射器の市場規模は安定した成長を示しており、CAGRで6.2%の成長が予測されています。世界中で、糖尿病、多発性硬化症、多数の生活習慣病の流行が、全体の市場成長を促進する見込みです。

当レポートでは、世界の使い捨て皮下注射器市場について調査分析し、市場力学、セグメント分析、地域分析、企業プロファイルなどを提供しています。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場スナップショット：世界の使い捨て皮下注射器市場
  • 世界の使い捨て皮下注射器市場：タイプ別（2021年）
  • 世界の使い捨て皮下注射器市場：エンドユーザー別（2021年）
  • 世界の使い捨て皮下注射器市場：地域別（2021年）
  • COVID-19の影響
  • 魅力的な投資提案：地域別（2021年）
  • 競合分析
    • 主な使い捨て皮下注射器市場ベンダーの市場ポジショニング
    • 使い捨て皮下注射器市場ベンダーが採用する戦略
    • 主な業界戦略

第3章 使い捨て皮下注射器市場：事業の見通しと市場力学

  • イントロダクション
  • 世界の使い捨て皮下注射器の市場金額（2020年～2030年）
  • 市場力学
    • 市場促進要因
    • 市場抑制要因
    • 主な課題
    • 主な機会
  • 促進要因と抑制要因の影響の分析
  • シーソー分析
  • ポーターのファイブフォースモデル
  • PESTEL分析

第4章 使い捨て皮下注射器市場：タイプ別（2020年～2030年）

  • 市場の概要
  • 成長と収益の分析：2021年対2030年
  • 市場セグメンテーション
    • インスリン注射器
    • マルチショット針注射器
    • 抽出用注射器
    • 歯科用注射器

第5章 使い捨て皮下注射器市場：エンドユーザー別（2020年～2030年）

  • 市場の概要
  • 成長と収益の分析：2021年対2030年
  • 市場セグメンテーション
    • 病院・診療所
    • 診断研究所
    • 糖尿病ケアセンター
    • その他（動物クリニック、採血センター）

第6章 北米の使い捨て皮下注射器市場（2020年～2030年）

  • 市場の概要
  • 使い捨て皮下注射器市場：タイプ別（2020年～2030年）
  • 使い捨て皮下注射器市場：エンドユーザー別（2020年～2030年）
  • 使い捨て皮下注射器市場：地域別（2020年～2030年）
    • 北米

第7章 英国・欧州連合の使い捨て皮下注射器市場（2020年～2030年）

  • 市場の概要
  • 使い捨て皮下注射器市場：タイプ別（2020年～2030年）
  • 使い捨て皮下注射器市場：エンドユーザー別（2020年～2030年）
  • 使い捨て皮下注射器市場：地域別（2020年～2030年）
    • 英国・欧州連合

第8章 アジア太平洋の使い捨て皮下注射器市場（2020年～2030年）

  • 市場の概要
  • 使い捨て皮下注射器市場：タイプ別（2020年～2030年）
  • 使い捨て皮下注射器市場：エンドユーザー別（2020年～2030年）
  • 使い捨て皮下注射器市場：地域別（2020年～2030年）
    • アジア太平洋

第9章 ラテンアメリカの使い捨て皮下注射器市場（2020年～2030年）

  • 市場の概要
  • 使い捨て皮下注射器市場：タイプ別（2020年～2030年）
  • 使い捨て皮下注射器市場：エンドユーザー別（2020年～2030年）
  • 使い捨て皮下注射器市場：地域別（2020年～2030年）
    • ラテンアメリカ

第10章 中東・アフリカの使い捨て皮下注射器市場（2020年～2030年）

  • 市場の概要
  • 使い捨て皮下注射器市場：タイプ別（2020年～2030年）
  • 使い捨て皮下注射器市場：エンドユーザー別（2020年～2030年）
  • 使い捨て皮下注射器市場：地域別（2020年～2030年）
    • 中東・アフリカ

第11章 企業プロファイル

  • Becton, Dickinson and Company
  • Smiths Medical
  • Terumo Corporation
  • Albert David Ltd.
  • Nipro Corporation
  • Medtronic plc
  • Thermo Fisher Scientific
  • Gerresheimer AG
  • B. Braun Medical Inc.
  • Hindustan Syringes & Medical Devices Limited
  • Changzhou Holinx Industries Co., Ltd.
  • CODAN Medizinische Gerate GmbH & Co KG
  • ISCON SURGICALS LTD.
図表

List of Tables

  • TABLE 1 Global Disposable Hypodermic Syringes Market By Type, 2020-2030, USD (Million)
  • TABLE 2 Global Disposable Hypodermic Syringes Market By End User, 2020-2030, USD (Million)
  • TABLE 3 North America Disposable Hypodermic Syringes Market By Type, 2020-2030, USD (Million)
  • TABLE 4 North America Disposable Hypodermic Syringes Market By End User, 2020-2030, USD (Million)
  • TABLE 5 UK and European Union Disposable Hypodermic Syringes Market By Type, 2020-2030, USD (Million)
  • TABLE 6 UK and European Union Disposable Hypodermic Syringes Market By End User, 2020-2030, USD (Million)
  • TABLE 7 Asia Pacific Disposable Hypodermic Syringes Market By Type, 2020-2030, USD (Million)
  • TABLE 8 Asia Pacific Disposable Hypodermic Syringes Market By End User, 2020-2030, USD (Million)
  • TABLE 9 Latin America Disposable Hypodermic Syringes Market By Type, 2020-2030, USD (Million)
  • TABLE 10 Latin America Disposable Hypodermic Syringes Market By End User, 2020-2030, USD (Million)
  • TABLE 11 Middle East and Africa Disposable Hypodermic Syringes Market By Type, 2020-2030, USD (Million)
  • TABLE 12 Middle East and Africa Disposable Hypodermic Syringes Market By End User, 2020-2030, USD (Million)

List of Figures

  • FIG. 1 Global Disposable Hypodermic Syringes Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Disposable Hypodermic Syringes Market: Quality Assurance
  • FIG. 5 Global Disposable Hypodermic Syringes Market, By Type, 2021
  • FIG. 6 Global Disposable Hypodermic Syringes Market, By End User, 2021
  • FIG. 7 Global Disposable Hypodermic Syringes Market, By Geography, 2021
  • FIG. 8 Global Disposable Hypodermic Syringes Market, By Type, 2021 Vs 2030, %
  • FIG. 9 Global Disposable Hypodermic Syringes Market, By End User, 2021 Vs 2030, %
  • FIG. 10 U.S. Disposable Hypodermic Syringes Market (US$ Million), 2020 - 2030
  • FIG. 11 Canada Disposable Hypodermic Syringes Market (US$ Million), 2020 - 2030
  • FIG. 12 Rest of North America Disposable Hypodermic Syringes Market (US$ Million), 2020 - 2030
  • FIG. 13 UK Disposable Hypodermic Syringes Market (US$ Million), 2020 - 2030
  • FIG. 14 Germany Disposable Hypodermic Syringes Market (US$ Million), 2020 - 2030
  • FIG. 15 Spain Disposable Hypodermic Syringes Market (US$ Million), 2020 - 2030
  • FIG. 16 Italy Disposable Hypodermic Syringes Market (US$ Million), 2020 - 2030
  • FIG. 17 France Disposable Hypodermic Syringes Market (US$ Million), 2020 - 2030
  • FIG. 18 Rest of Europe Disposable Hypodermic Syringes Market (US$ Million), 2020 - 2030
  • FIG. 19 China Disposable Hypodermic Syringes Market (US$ Million), 2020 - 2030
  • FIG. 20 Japan Disposable Hypodermic Syringes Market (US$ Million), 2020 - 2030
  • FIG. 21 India Disposable Hypodermic Syringes Market (US$ Million), 2020 - 2030
  • FIG. 22 Australia Disposable Hypodermic Syringes Market (US$ Million), 2020 - 2030
  • FIG. 23 South Korea Disposable Hypodermic Syringes Market (US$ Million), 2020 - 2030
  • FIG. 24 Rest of Asia Disposable Hypodermic Syringes Market (US$ Million), 2020 - 2030
  • FIG. 25 Brazil Disposable Hypodermic Syringes Market (US$ Million), 2020 - 2030
  • FIG. 26 Mexico Disposable Hypodermic Syringes Market (US$ Million), 2020 - 2030
  • FIG. 27 Rest of Latin America Disposable Hypodermic Syringes Market (US$ Million), 2020 - 2030
  • FIG. 28 GCC Disposable Hypodermic Syringes Market (US$ Million), 2020 - 2030
  • FIG. 29 Africa Disposable Hypodermic Syringes Market (US$ Million), 2020 - 2030
  • FIG. 30 Rest of Middle East and Africa Disposable Hypodermic Syringes Market (US$ Million), 2020 - 2030
目次
Product Code: 139014-08-22

Disposable hypodermic syringes market to exhibit dynamic growth during the forecast period

The global disposable hypodermic syringes market is witnessing a steady growth, expected to grow at a CAGR of 6.2%. Worldwide, the increasing prevalence of diabetes, multiple sclerosis, and numerous lifestyle diseases will drive the overall market growth. Globally, rising number of surgeries, increased growth of biologics, advancement in hypodermic syringes with fixed dosage, low cost medical devices, and decreased microbial contamination risk along with reduced medication errors are key factors driving the overall growth of the disposable hypodermic syringes market. Additionally, enhanced R&D for disposable syringes, growth in the general and specialized syringes, increasing physician visits and increased product penetration in the hospitals and clinics will further spur revenue growth in the near future.

Disposable Hypodermic Syringes Market

Insulin syringes expected to register higher growth by the end of 2027

Increasing prevalence of Type 1 diabetes and Type 2 diabetes in children and adults will upsurge the demand for insulin delivery. According to the recent edition of the International Diabetes Federation (IDF) Diabetes Atlas 2017, around 424.9 million people were living with diabetes worldwide and estimated to increase by 48% by the end of 2045. Additionally, a high prevalence of multiple sclerosis and other lifestyle diseases will upsurge the overall demand in the near future. Increased use of single-use dental hypodermic syringes for daily operations will drive revenue growth. Utilization of multishot needle syringes and extraction syringes show steady growth during the forecast period due to its ease of operation, enhanced safety, low cost, and availability.

Diabetic care centers segment to witness a significant CAGR

Expansion of diabetes care and services along with increased awareness about overall health management on a global scale will drive the overall growth of the market. Top institutes and organizations in collaboration with healthcare companies are expanding the services in the untapped markets. For e.g. American Association of Diabetes Educators, NCPA Foundation and others. Increased preference for disposable hypodermic syringes in hospitals and clinics as compared to traditional syringes at low cost along with no chances of cross-contamination will show promising growth on a global scale. Increasing hospital admissions, and expanding outpatient clinics and centers will increase the volume of disposable hypodermic syringes mainly for insulin delivery, vaccination, anesthesia administration and extraction of blood.

Increased research and development with strong product portfolio in the developed regions

Major players in the disposable hypodermic syringes market are Becton, Dickinson and Company, Smiths Medical, Terumo Corporation, Albert David Ltd., Nipro Corporation, Medtronic plc, Thermo Fisher Scientific, Gerresheimer AG, B. Braun Medical Inc., Hindustan Syringes & Medical Devices Limited, Changzhou Holinx Industries Co., Ltd., CODAN Medizinische Gerate GmbH & Co KG, ISCON SURGICALS LTD. and others. Innovative product launches with higher patient safety & compatibility, low cost products, partnerships, new technology expansion, and improved R&D on disposable syringes will further spur revenue growth globally.

Historical & Forecast Period

This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Disposable Hypodermic Syringes market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report

Micro and macro environment factors that are currently influencing the Disposable Hypodermic Syringes market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

ATTRIBUTE DETAILS

Research Period 2020-2030

Base Year 2021

Forecast Period 2022-2030

Historical Year 2020

Unit USD Million

Segmentation

Type

Insulin Syringes

Multishot Needle Syringes

Extraction Syringes

Dental Syringes

End User

Hospitals and Clinics

Diagnostic Laboratories

Diabetic Care Centers

Others (Veterinary Clinics, Blood Collection Centers)

Region Segment (2020-2030; US$ Million)

North America

U.S.

Canada

Rest of North America

UK and European Union

UK

Germany

Spain

Italy

France

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East and Africa

GCC

Africa

Rest of Middle East and Africa

Global Impact of COVID-19 Segment (2020-2021; US$ Million )

Pre COVID-19 situation

Post COVID-19 situation

Key questions answered in this report:

What are the key micro and macro environmental factors that are impacting the growth of Disposable Hypodermic Syringes market?

What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2030.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the Disposable Hypodermic Syringes market?

Which is the largest regional market for Disposable Hypodermic Syringes market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving Disposable Hypodermic Syringes market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the Disposable Hypodermic Syringes market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Disposable Hypodermic Syringes Market
  • 2.2. Global Disposable Hypodermic Syringes Market, By Type, 2021 (US$ Million)
  • 2.3. Global Disposable Hypodermic Syringes Market, By End User, 2021 (US$ Million)
  • 2.4. Global Disposable Hypodermic Syringes Market, By Geography, 2021 (US$ Million)
  • 2.5. Impact of Covid 19
  • 2.6. Attractive Investment Proposition by Geography, 2021
  • 2.7. Competitive Analysis
    • 2.7.1. Market Positioning of Key Disposable Hypodermic Syringes Market Vendors
    • 2.7.2. Strategies Adopted by Disposable Hypodermic Syringes Market Vendors
    • 2.7.3. Key Industry Strategies

3. Disposable Hypodermic Syringes Market: Business Outlook & Market Dynamics

  • 3.1. Introduction
  • 3.2. Global Disposable Hypodermic Syringes Market Value, 2020 - 2030, (US$ Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers
    • 3.3.2. Market Restraints
    • 3.3.3. Key Challenges
    • 3.3.4. Key Opportunities
  • 3.4. Impact Analysis of Drivers and Restraints
  • 3.5. See-Saw Analysis
  • 3.6. Porter's Five Force Model
    • 3.6.1. Supplier Power
    • 3.6.2. Buyer Power
    • 3.6.3. Threat Of Substitutes
    • 3.6.4. Threat Of New Entrants
    • 3.6.5. Competitive Rivalry
  • 3.7. PESTEL Analysis
    • 3.7.1. Political Landscape
    • 3.7.2. Economic Landscape
    • 3.7.3. Technology Landscape
    • 3.7.4. Legal Landscape
    • 3.7.5. Social Landscape

4. Disposable Hypodermic Syringes Market: By Type, 2020-2030, USD (Million)

  • 4.1. Market Overview
  • 4.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 4.3. Market Segmentation
    • 4.3.1. Insulin Syringes
    • 4.3.2. Multishot Needle Syringes
    • 4.3.3. Extraction Syringes
    • 4.3.4. Dental Syringes

5. Disposable Hypodermic Syringes Market: By End User, 2020-2030, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 5.3. Market Segmentation
    • 5.3.1. Hospitals and Clinics
    • 5.3.2. Diagnostic Laboratories
    • 5.3.3. Diabetic Care Centers
    • 5.3.4. Others (Veterinary Clinics, Blood Collection Centers)

6. North America Disposable Hypodermic Syringes Market, 2020-2030, USD (Million)

  • 6.1. Market Overview
  • 6.2. Disposable Hypodermic Syringes Market: By Type, 2020-2030, USD (Million)
  • 6.3. Disposable Hypodermic Syringes Market: By End User, 2020-2030, USD (Million)
  • 6.4.Disposable Hypodermic Syringes Market: By Region, 2020-2030, USD (Million)
    • 6.4.1.North America
      • 6.4.1.1. U.S.
      • 6.4.1.2. Canada
      • 6.4.1.3. Rest of North America

7. UK and European Union Disposable Hypodermic Syringes Market, 2020-2030, USD (Million)

  • 7.1. Market Overview
  • 7.2. Disposable Hypodermic Syringes Market: By Type, 2020-2030, USD (Million)
  • 7.3. Disposable Hypodermic Syringes Market: By End User, 2020-2030, USD (Million)
  • 7.4.Disposable Hypodermic Syringes Market: By Region, 2020-2030, USD (Million)
    • 7.4.1.UK and European Union
      • 7.4.1.1. UK
      • 7.4.1.2. Germany
      • 7.4.1.3. Spain
      • 7.4.1.4. Italy
      • 7.4.1.5. France
      • 7.4.1.6. Rest of Europe

8. Asia Pacific Disposable Hypodermic Syringes Market, 2020-2030, USD (Million)

  • 8.1. Market Overview
  • 8.2. Disposable Hypodermic Syringes Market: By Type, 2020-2030, USD (Million)
  • 8.3. Disposable Hypodermic Syringes Market: By End User, 2020-2030, USD (Million)
  • 8.4.Disposable Hypodermic Syringes Market: By Region, 2020-2030, USD (Million)
    • 8.4.1.Asia Pacific
      • 8.4.1.1. China
      • 8.4.1.2. Japan
      • 8.4.1.3. India
      • 8.4.1.4. Australia
      • 8.4.1.5. South Korea
      • 8.4.1.6. Rest of Asia Pacific

9. Latin America Disposable Hypodermic Syringes Market, 2020-2030, USD (Million)

  • 9.1. Market Overview
  • 9.2. Disposable Hypodermic Syringes Market: By Type, 2020-2030, USD (Million)
  • 9.3. Disposable Hypodermic Syringes Market: By End User, 2020-2030, USD (Million)
  • 9.4.Disposable Hypodermic Syringes Market: By Region, 2020-2030, USD (Million)
    • 9.4.1.Latin America
      • 9.4.1.1. Brazil
      • 9.4.1.2. Mexico
      • 9.4.1.3. Rest of Latin America

10. Middle East and Africa Disposable Hypodermic Syringes Market, 2020-2030, USD (Million)

  • 10.1. Market Overview
  • 10.2. Disposable Hypodermic Syringes Market: By Type, 2020-2030, USD (Million)
  • 10.3. Disposable Hypodermic Syringes Market: By End User, 2020-2030, USD (Million)
  • 10.4.Disposable Hypodermic Syringes Market: By Region, 2020-2030, USD (Million)
    • 10.4.1.Middle East and Africa
      • 10.4.1.1. GCC
      • 10.4.1.2. Africa
      • 10.4.1.3. Rest of Middle East and Africa

11. Company Profile

  • 11.1. Becton, Dickinson and Company
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Portfolio
    • 11.1.4. Strategic Initiatives
  • 11.2. Smiths Medical
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Portfolio
    • 11.2.4. Strategic Initiatives
  • 11.3. Terumo Corporation
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Portfolio
    • 11.3.4. Strategic Initiatives
  • 11.4. Albert David Ltd.
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Portfolio
    • 11.4.4. Strategic Initiatives
  • 11.5. Nipro Corporation
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Portfolio
    • 11.5.4. Strategic Initiatives
  • 11.6. Medtronic plc
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Portfolio
    • 11.6.4. Strategic Initiatives
  • 11.7. Thermo Fisher Scientific
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Portfolio
    • 11.7.4. Strategic Initiatives
  • 11.8. Gerresheimer AG
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Portfolio
    • 11.8.4. Strategic Initiatives
  • 11.9. B. Braun Medical Inc.
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Portfolio
    • 11.9.4. Strategic Initiatives
  • 11.10. Hindustan Syringes & Medical Devices Limited
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Portfolio
    • 11.10.4. Strategic Initiatives
  • 11.11. Changzhou Holinx Industries Co., Ltd.
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Portfolio
    • 11.11.4. Strategic Initiatives
  • 11.12. CODAN Medizinische Gerate GmbH & Co KG
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Portfolio
    • 11.12.4. Strategic Initiatives
  • 11.13. ISCON SURGICALS LTD.
    • 11.13.1. Company Overview
    • 11.13.2. Financial Performance
    • 11.13.3. Product Portfolio
    • 11.13.4. Strategic Initiatives